Desh Rakshak Aushdhalaya Ltd.
Snapshot View

4.73 ▼0%

07 October 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deshrakshak.in
Market Cap 2.10 Cr.
Enterprise Value(EV) 6.59 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.05 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 4.50 Trailing Twelve Months Ending 2022-06
Industry PE 35.11 Trailing Twelve Months Ending 2022-06
Book Value / Share 20.46 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.23 Calculated using Price: 4.73
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.44 Cr. 4,438,324 Shares
FaceValue 10
Company Profile
The company is the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by its Ancient Seers & Sages. The medicines are categorized into Patent & Proprietary (Classical) Medicines. The company is currently manufacturing around 400 products (Patent and Classical mix). And all these medicines are manufactured as per the prescribed norms and standards of the Indian Government.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
3 Month
+10.0%
6 Month
+10.0%
1 Year
+20.97%
2 Year
+10.26%
5 Year
-33.66%
10 Year
-59.05%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.05 0.37 4.36 4.03 3.90 4.40 3.83 5.05 5.49
Return on Capital Employed (%) 2.55 2.54 5.98 5.33 5.54 5.99 5.77 6.69 6.44
Return on Assets (%) 0.73 0.26 2.96 2.78 2.69 3.01 2.56 3.12 3.13

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 7 7 7 8 8 8 9 9 9
Non Curr. Liab. 1 1 1 1 1 1 2 3 4 5
Curr. Liab. 2 2 2 2 2 2 2 3 3 3
Minority Int.
Equity & Liab. 9 10 10 10 11 11 12 15 16 17
Non Curr. Assets 5 5 6 6 7 7 8 9 11 11
Curr. Assets 4 5 4 4 4 4 4 5 6 6
Misc. Exp. not W/O
Total Assets 9 10 10 10 11 11 12 15 16 17

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 4 4 5 5 5 6 5 7 6 6
Other Income 0 0 0 0 0 0 0 0
Total Income 4 4 5 5 5 6 5 7 6 6
Total Expenditure -3 -4 -4 -4 -4 -5 -4 -6 -5 -4
PBIDT 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 1 1 1 1 1 1 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 1 0 0 -1 1 1 0
Cash Fr. Inv. 0 0 0 -1 -1 0 0 -1 -1 -2
Cash Fr. Finan. 0 1 1 1
Net Change 0 0 0 1 -1 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 1 0 0 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28
Public 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 24 Nov 2022
Non-Applicability Of Disclosure Of Related Party Transactions Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 30Th September 2022
With reference to the above subject the provisions of Regulation 23 (9) read with Regulation 15 (2) Applicability criteria of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 the provisions mentioned in Regulation 23(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 relating to submission of related party disclosure on half yearly basis is not applicable to the Company since the companys paid up equity share capital is less than 10 crores and net worth is less than 25 crores as on the last day of the previous financial year.However as there are no related party transactions for the half year ended 30th day of September 2022 in the ordinary course of business hence the company on suo-moto basis not providing any Disclosure under regulation 23(9) as good governance practice for the half year ended on 30th September 2022.
Tue, 15 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submit the newspaper advertisement cuttings of the Un-Audited Financial Results for the Second Quarter and Half year Ended on 30.09.2022 published pursuant to regulation 47(1)(b) of SEBI(Listing Obligations and Disclosure requirements) Regulations 2015
Mon, 14 Nov 2022
Submission Of Un-Audited Financial Results For The Second Quarter And Half Year Ended On 30.09.2022.<BR> <BR>
Pursuant to Regulation 33 of SEBl (LODR) Regulations 2015 mentioned in the captioned subject we are enclosing herewith Statement of Un-Audited Financial Results for the Second Quarter and Half year ended on 30th September 2022 along with Statement of Assets and liabilities and Cash Flow Statement for the half year ended 30.09.2022 which has been approved by the Board of Directors of the Company at its Meeting held on 14th November 2022.

Also please find enclosed the Limited Review Report for the Second Quarter and Half year ended on 30th September 2022 by our Auditors Anil Jain & Co. in respect of the above results.

Technical Scans View Details >>

No Scans Found

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Desh Rakshak Aushdhalaya Ltd.

What is Desh Rakshak Aushdh share price?

Can I buy Desh Rakshak Aushdh shares now?

What is the Market Cap of Desh Rakshak Aushdh?

What are the key metrics to analyse Desh Rakshak Aushdh?

What is the 52 Week High and Low of Desh Rakshak Aushdh?